Deferoxamine bulk supplier for pharma manufacturers

Deferoxamine 500 mg/vial, 2 g/vial Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder for injection

Available Strengths: 500 mg/vial, 2 g/vial

Reference Brands: Desferal

Category: Anemia

Deferoxamine (Desferal) treats acute and chronic iron overload. Available in 500 mg and 2 g vials. Trusted for B2B pharma supply globally.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Deferoxamine (Desferal®) is a trusted parenteral iron chelator used in the treatment of acute iron poisoning and chronic iron overload due to frequent blood transfusions, especially in thalassemia and sickle cell disease. Available as 500 mg and 2 g lyophilized powder for injection, it is administered via IV, IM, or subcutaneous infusion. Marketed under the brand Desferal in the US and EU, it’s manufactured under GMP-compliant standards for hospital and clinical use. Ideal for global B2B pharmaceutical procurement. Contact us for bulk export, COAs, and regulatory support documents.

Deferoxamine — third party manufacturing & bulk supply

Deferoxamine 500 mg/vial, 2 g/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Deferoxamine is supplied as Lyophilized powder for injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Deferoxamine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Deferoxamine →

Back to Listing

Frequently Asked Questions

Deferoxamine is used to treat chronic iron overload caused by repeated blood transfusions, commonly seen in conditions like thalassemia, sickle cell disease, and certain anemias. It is also used for acute iron poisoning. It works by binding excess iron and helping the body eliminate it.

Deferoxamine is made from the active compound deferoxamine mesylate, a chelating agent that binds free iron and forms a stable complex that can be excreted from the body.

Deferoxamine is marketed under trade names such as Desferal and other region-specific brands.

Major manufacturers include Novartis (producer of Desferal) and several licensed pharmaceutical companies in different regions who produce generic formulations.

The generic name of the product is deferoxamine mesylate.

It is available under brand names such as Desferal, with additional region-specific branded generics depending on the market.

Deferoxamine is manufactured in multiple countries including Switzerland, the United States, and India, depending on the pharmaceutical company producing it. The exact manufacturing location varies by manufacturer.